Gene · 5740
Papers1,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma. | Sci Rep | 2024 | 39060344 | PubTator, text mining | PubMed |
| A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data. | Clin Transl Sci | 2024 | 38853370 | PubTator, text mining | PubMed |
| Prostacyclin synthase deficiency exacerbates systemic inflammatory responses in lipopolysaccharide-induced septic shock in mice. | Inflamm Res | 2024 | 38832966 | PubTator, text mining | PubMed |
| Identification of Prostaglandin I2 Synthase Rare Variants in Patients With Williams Syndrome and Severe Peripheral Pulmonary Stenosis. | J Am Heart Assoc | 2024 | 38639351 | PubTator, text mining | PubMed |
| Identification and validation of an endoplasmic-reticulum-stress-related gene signature as an effective diagnostic marker of endometriosis. | PeerJ | 2024 | 38549776 | PubTator, text mining | PubMed |
| Crosstalk of cuproptosis-related subtypes, establishment of a prognostic signature, and immune infiltration characteristics in gastric cancer. | Heliyon | 2024 | 38298669 | PubTator, text mining | PubMed |
| The relationship between kidney disease and mitochondria: a bibliometric study. | Ren Fail | 2024 | 38263699 | PubTator, text mining | PubMed |
| Multifunctional nanoparticle-mediated combining therapy for human diseases. | Signal Transduct Target Ther | 2024 | 38161204 | PubTator, text mining | PubMed |
| Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I 2 Receptor. | J Am Soc Nephrol | 2024 | 38062563 | PubTator, text mining | PubMed |
| Widening the Prostacyclin Paradigm: Tissue Fibroblasts Are a Critical Site of Production and Antithrombotic Protection. | Arterioscler Thromb Vasc Biol | 2024 | 37823267 | PubTator, text mining | PubMed |
| SIRT1 and thrombosis. | Front Mol Biosci | 2023 | 38304233 | PubTator, text mining | PubMed |
| Chronic Pelvic Pain, Vulvar Pain Disorders, and Proteomics Profiles: New Discoveries, New Hopes. | Biomedicines | 2023 | 38275362 | PubTator, text mining | PubMed |
| Exploring Omega-3's Impact on the Expression of Bone-Related Genes in Meagre (Argyrosomus regius). | Biomolecules | 2023 | 38254657 | PubTator, text mining | PubMed |
| 28S rRNA-Derived Fragments Represent an Independent Molecular Predictor of Short-Term Relapse in Prostate Cancer. | Int J Mol Sci | 2023 | 38203408 | PubTator, text mining | PubMed |
| Cyclooxygenase-2 Blockade Is Crucial to Restore Natural Killer Cell Activity before Anti-CTLA-4 Therapy against High-Grade Serous Ovarian Cancer. | Cancers (Basel) | 2023 | 38201508 | PubTator, text mining | PubMed |
| Reviving intimacy: Penile rehabilitation strategies for men after prostate cancer treatment. | Prostate Int | 2023 | 38196554 | PubTator, text mining | PubMed |
| NAD+ associated genes as potential biomarkers for predicting the prognosis of gastric cancer. | Oncol Res | 2023 | 38186577 | PubTator, text mining | PubMed |
| Diabetic Retinopathy and Cardiovascular Disease: A Literature Review. | Diabetes Metab Syndr Obes | 2023 | 38164419 | PubTator, text mining | PubMed |
| The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics. | Oxid Med Cell Longev | 2023 | 38155869 | PubTator, text mining | PubMed |
| ARID1A loss activates MAPK signaling via DUSP4 downregulation. | J Biomed Sci | 2023 | 38071325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5740/papers?page=4